|
Volumn 25, Issue 5, 1991, Pages 815-822
|
Transferrin-adriamycin conjugates which inhibit tumor cell proliferation without interaction with DNA inhibit plasma membrane oxidoreductase and proton release in K562 cells
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DOXORUBICIN;
FERRICYANIDE;
OXIDOREDUCTASE;
PROTON;
TRANSFERRIN;
ARTICLE;
CANCER INHIBITION;
CELL GROWTH;
CELL MEMBRANE;
CELL STRAIN K 562;
DRUG CONJUGATION;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
OXIDATION REDUCTION REACTION;
PRIORITY JOURNAL;
PROTON SODIUM EXCHANGE;
PROTON TRANSPORT;
TUMOR CELL;
CARRIER PROTEINS;
CELL DIVISION;
DOXORUBICIN;
DRUG CARRIERS;
ELECTRON TRANSPORT;
ENZYME ACTIVATION;
HUMAN;
LEUKEMIA, ERYTHROBLASTIC, ACUTE;
MEMBRANE PROTEINS;
MULTIENZYME COMPLEXES;
NADH, NADPH OXIDOREDUCTASES;
NEOPLASM PROTEINS;
OXIDATION-REDUCTION;
PROTONS;
RECEPTORS, TRANSFERRIN;
SODIUM-HYDROGEN ANTIPORTER;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
TRANSFERRIN;
TUMOR CELLS, CULTURED;
|
EID: 0026329321
PISSN: 01585231
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (21)
|
References (0)
|